• Share
  • Email
  • Print
  • Font Size

Jan E. Murray

Partner
Boston
+1.617.261.3191
Fax +1.617.261.3175

Primary Practice

Secondary Practices

Education

  • J.D., Case Western Reserve University School of Law, 1978
  • B.A., University of Vermont, 1974

Admissions

  • Bar of Ohio
  • Supreme Court of Ohio
  • Biography Overview
  • Additional Background
  • Representative Work
Jan Murray is a partner in the firm’s Boston office. Ms. Murray focuses her practice on health care and life sciences law. An experienced health care lawyer, Ms. Murray has represented hospital systems and academic medical center clients in numerous complex transactions and regulatory projects and has advised on such matters as Medicare reimbursement, Stark and anti-kickback compliance, nonprofit corporate law and governance, and federal tax exemption. She has also represented academic medical center clients on faculty and research matters. Ms. Murray has significant experience in representing life science companies in conducting global clinical trials and has represented healthcare clients in developing ventures in Asia and the Middle East.

Professional Background

Prior to joining K&L Gates, Ms. Murray was the Deputy Chief Legal Officer of the Cleveland Clinic Foundation, one of the nation’s leading medical research and international referral centers, where she served as second in command of a large law department. Prior to joining the staff of the Clinic in 2007, Ms. Murray was a partner with another large law firm and represented domestic and international health care providers and life science companies. Prior to that, Ms. Murray served as Vice President and General Counsel of a community hospital system.

Achievements

  • Chosen as "Leading Lawyer" by Inside Business, December 2009
  • Chosen an "Ohio Super Lawyer" by attorney peers statewide for several consecutive years since 2004
  • Selected for inclusion in the 2008 volume of Best Lawyers in America

Professional/Civic Activities

  • American Medical Group Association (Present)
    • Member, Technical Advisory Committee, Accountable Care Organizations, 2010-present
  • American Health Lawyers Association (Present)
    • Member, Task Force on Accountable Care Organizations, 2010-present
    • Chairman, Academic Medical Centers Special Interest Substantive Law Committee,   2000-2003
    • In this capacity, oversaw the publications and conferences designed for AHLA members representing academic medical centers 
    • Vice Chairman, Academic Medical Centers Special Interest Substantive Law Committee, 1998-2000
  • American Bar Association (Present)
    • Member, Subcommittee of the Model Nonprofit Corporation Act of the Corporate Laws Committee
    • As a member of this subcommittee, participated in the preparation of  a revision of the Model Nonprofit Corporation Act, published by the ABA in April 2009
    • Member, Coordinating Committee for Nonprofit Governance
    • As a member of this Committee, participated in the drafting of the treatise published by the ABA entitled Guide to Nonprofit Corporate Governance in the Wake of Sarbanes-Oxley
  • Cleveland Bar Association (Present)
    • Chairman - Health Law Council, 1995-1996

Speaking Engagements

  • "The Future of Accountable Care Organizations," Panelist, Annual Healthcare Law Institute, Greater Cleveland Bar Association, April 2011.
  • "US Healthcare Providers and International Activity," Panelist, Legal and Compliance Issues in Biomedical Innovation, American Health Lawyers Association, Washington, DC, January 2011.
  • "Care Coordination Models-How Do We Get There?" Panelist on Webinar sponsored by the American Health Lawyers Association, April 28, 2010.
  • "Compliance Issues in Overseas Health Research Projects" (with C. Hermes), Academic Medical Centers Annual Conference, American Health Lawyers Association, Washington, DC, January 2009.
  • "Going Global: The Globalization of Health Care and Medical Education" (with N. Forbes), Annual Conference, American Health Lawyers Association, San Francisco, CA, June 2008.
  • "Regulation of Clinical Trials in the EU and US:  A Comparative Review" (with C. Spontoni), Clinical Trials Logistics, SMI Conference, London, United Kingdom, March 2007.
  • Moderator, "Deal Makers and Breakers in Negotiation of Clinical Trial Agreements,"  6th Annual Conference on Managing Legal Risks in Structuring and Conducting Clinical Trials, American Conference Institute, New York, NY, February 2007.
  • Panelist, "Conducting Clinical Trials Abroad," BayBIO Annual Conference, San Francisco, CA, June 2006.
  • "Intellectual Property, Research Contracts and the Academic Medical Center" (with C. Horrigan), Academic Medical Centers Annual Conference, American Health Lawyers Association, Washington, DC, January 2006.
  • Panelist, "Search for Safe and Effective Cures:  Development and Management of Clinical Trials," BayBIO Annual Conference, San Francisco, CA, April 2005.
  • Panelist, "Disclosure of Negative Clinical Trial Results," International Biomedical Society, Palo Alto, CA, December 2004.
  • "New Drug Approval Requirement," Food and Drug Law Institute, Washington, DC, October 2004.
  • Panelist, "Contracting with CROs," BIO 2004 Annual International Conference, San Francisco, CA, June 2004.
  • "Regulatory Framework for Marketing Approval of Drugs and Devices," BioHouston, Houston, TX, April 2004.
  • "Pediatric Research Issues," Academic Medical Centers Annual Conference sponsored by the American Health Lawyers Association, Washington, DC, January 2003.
  • "Regulation of Biomedical Research and Technology Transfer," American Health Lawyers Annual Conference, San Francisco, CA, June 2002.
  • "Navigating the Clinical Trials Process:  US/EU Comparison" (with C. Spontoni), First Annual Irish BIO Conference, Dublin, Ireland, November 2002.
  • Panelist, "The Continuing Saga of Nonprofit Healthcare Mergers and Acquisitions," American Bar Association, Business Law Section, Spring conference, Columbus, OH, March 2000.
  • Panelist, "The Boston Medical Center Decision: What Is in Store for Teaching Hospitals," American Health Lawyers Association, National Teleconference, February 23, 2000; quoted in American Hospital Association News, February 2000.
  • "The Law of Privilege in the Context of Compliance Investigations," Health Care Compliance Association Conference, Chicago, IL, July 1999.
  • "Disclosure of Medicare Billing Errors and Misconduct" (with G. Imperato), American Health Lawyers Association, Institute on Medicare and Medicaid Payment Issues, Baltimore, MD, March 1999.
  • "Ethical Issues for Lawyers in Corporate Compliance Programs," Annual Health Care Law Institute, Cleveland Bar Association, Cleveland, OH, April 1998.
  • "Hospital and Physician Relationships," Cleveland-Marshall College of Law, Continuing Legal Education Seminar, Cleveland, OH, October 1998.
  • Panelist, "Conversion of Nonprofit Healthcare Organizations into For-Profit Entities," American Bar Association Conference, Boston, MA, April 1997.
  • "Hospital/Physician Legal Issues," Cleveland Bar Association, Health Law Institute, Cleveland, OH, May 1997.

Publications

  • “Healthcare Opportunities in India—Executive Summary,” American Health Lawyers Association, October 2008.
  • “2006 Advisory Opinions and Their Relevance to AMCs,” in Teaching Hospitals and Academic Medical Centers , American Health Lawyers Association, Spring 2006.
  • Contributor to Best Practices for Food and Drug Law:  Leading Lawyers on FDA Approval Strategies, Industry Regulations and Client Communications, Aspatore Books, October 2005.
  • “Legal Issues Related to the Conduct of Multinational Clinical Trials by US Entities,” in Steiner, J., ed., Clinical Research Law and Compliance Handbook, Jones & Bartlett, August 2005.
  • Contributor to Guide to Nonprofit Corporate Governance in the Wake of Sarbanes-Oxley, American Bar Association, June 2005.
  • “Securing Informed Consent for Research Participation: Recent Controversies,” in   The   Health Lawyer,   American Health Lawyers Association,   January 2002.
  • “European Union Trade Regulations Affecting Entry to the European Market for Pharmaceutical and Medical Device Manufacturers,” with A. Mencik in Weiner, W., ed., Global Health Care Markets: A Comprehensive Guide to Regions, Trends and Opportunities Shaping the International Health Arena, John Wiley & Sons, September 2000.
  • “Disclosure of Corporate Compliance Matters by Healthcare Providers,” Practical Lawyer, American Bar Association, March 1999.
  • Represented hospitals and academic medical centers on internal compliance investigations related to billing compliance and compliance with healthcare integrity statutes;
  • Advised large academic medical center on launching of web-based second opinion program and subsequent marketing of program to large corporations;
  • Represented faculty practice plan cooperative in the integration of all faculty practice plans into newly organized entity formed by an academic medical center;
  • Represented large multiple hospital system in the review of all physician relationships for compliance with Stark and anti-kickback laws; assisted in the formation of new automated system for tracking all relationships and development of new policies and procedures;
  • Represented hospital-affiliated physician organization in the formation of highly clinically integrated program and subsequent negotiation of payer contract for the program;
  • Assisted various clients in development or management of hospitals in Asia and the Middle East;
  • Represented hospitals in the acquisition of other hospitals and physician groups;
  • Represented life science companies in launching global clinical trials including negotiation of CRO contracts and clinical trial agreements and assistance with various regulatory matters in foreign jurisdictions in South America, Europe and Asia;
  • Advised biotechnology and medical device companies on marketing and sales of drugs and devices including application of anti-kickback statute.
© 2012 K&L Gates LLP. All Rights Reserved.  |